Vote for the Best Clinical Product of 2020 in the Scientists’ Choice Awards

We are delighted to announce that our BioFire® Respiratory 2.1 (RP2.1) Panel has been nominated in the Best New Clinical Product of 2020 category!

BioFire Syndromic Trends Website Updated with SARS-CoV-2 Data

The public-facing SyndromicTrends.com website now includes detection-rate information for the BioFire® Respiratory 2.1 Panel, including data for SARS-CoV-2!

Remembering Thomas Brock, the Scientist Who Transformed Biotechnology

Thomas Brock is remembered for discovering Thermus aquaticus, a type of heat-resistant bacteria that makes our work here at BioFire Diagnostics possible.

BioFire® Respiratory 2.1 (RP2.1) Panel Updates and New Features

The BioFire Respiratory 2.1 Panel was the first respiratory panel to be granted FDA De Novo marketing authorization for SARS-CoV-2 detection. Learn more.

The Benefit of Point-of-Care Diagnostic Testing

Point-of-care diagnostic testing has many benefits including being more convenient for patients. Learn about BioFire's point-of-care testing solutions.

How Does Molecular Diagnostic Testing Work?

Molecular diagnostics tests can provide laboratories with critical advances in accuracy & speed compared to traditional standard of care methods.

Lab Professionals Save Lives: Recognizing Lab Week 2021

Laboratories face constant demands to do more with less. Read 5 ways to optimize your lab for efficiency from equipment to processes.

World Meningitis Day 2021

April 24, is World Meningitis Day—24 hours devoted to raising global awareness about a dangerous infectious disease that can affect anyone.

Five Things to Consider for Optimal Lab Efficiency

Laboratories face constant demands to do more with less. Read 5 ways to optimize your lab for efficiency from equipment to processes.

What is Sepsis?

/
Sepsis is the result of a body’s extreme response to an infection & at least 1.7 million adults in the US develop sepsis every year. Learn more about sepsis.